National Health Investors (NHI) Stock Price, News & Analysis

Company Overview

National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust that owns and finances healthcare real estate. The company focuses primarily on properties serving older adults and patients requiring specialized care, including independent living, assisted living, memory care, skilled nursing and continuing care retirement communities.

NHI generally leases its properties to healthcare and senior-living operators under long-term agreements, including primarily triple-net leases, under which tenants are typically responsible for property-level operating expenses, maintenance and taxes. The company also invests in medical office buildings and other healthcare-related real estate.

Founded in 1991, National Health Investors serves markets across the United States through a diversified portfolio of healthcare properties. Its assets are operated by third-party healthcare providers and senior-housing companies, giving NHI exposure to demand for senior-living and healthcare services without directly providing most of those services itself.

Key Stats

• Today's Range: $67.36 to $68.90
• 50-Day Range: $67.68 to $80.99
• 52-Week Range: $67.36 to $91.38
• Volume: 707,310 shs
• Average Volume: 333,702 shs
• Market Capitalization: $3.32 billion
• P/E Ratio: 19.56
• Dividend Yield: 5.44%
• Price Target: $82.25
• Consensus Rating: Moderate Buy

National Health Investors Stock Analysis - MarketRank™

National Health Investors scored higher than 81% of companies evaluated by MarketBeat, and ranked 72nd out of 184 stocks in the real estate sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.0 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

National Health Investors has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on no strong buy ratings, 6 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

National Health Investors has a consensus price target of $82.25, representing about 21.5% upside from its current price of $67.68.

Amount of Analyst Coverage

National Health Investors has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 5.04%

Earnings Growth

Earnings for National Health Investors are expected to grow by 5.04% in the coming year, from $4.76 to $5.00 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of National Health Investors is 19.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of National Health Investors is 19.56, which means that it is trading at a less expensive P/E ratio than the Real Estate sector average P/E ratio of about 27.82.

Price to Earnings Growth Ratio

National Health Investors has a PEG Ratio of 3.62. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

National Health Investors has a P/B Ratio of 2.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.72% of the float of National Health Investors has been sold short.

Short Interest Ratio / Days to Cover

National Health Investors has a short interest ratio ("days to cover") of 7.91.

Change versus previous month

Short interest in National Health Investors has recently increased by 3.81%, indicating that investor sentiment is decreasing.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

National Health Investors is a leading dividend payer. It pays a dividend yield of 5.43%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

National Health Investors does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of National Health Investors is 106.36%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, National Health Investors will have a dividend payout ratio of 73.60% next year. This indicates that National Health Investors will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.52

News Sentiment

National Health Investors has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Real Estate companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for National Health Investors this week, compared to 2 articles on an average week.

Search Interest

Only 3 people have searched for NHI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added National Health Investors to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, National Health Investors insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.70% of the stock of National Health Investors is held by insiders.

Percentage Held by Institutions

62.51% of the stock of National Health Investors is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 8/7 Dividend: 6/30/2026
• Ex-Dividend for 8/7 Dividend: 6/30/2026
• Dividend Payable: 8/07/2026
• Last Earnings: 8/10/2026
• Today: 9/21/2026
• Record date for 11/6 Dividend: 9/30/2026
• Ex-Dividend for 11/6 Dividend: 9/30/2026
• Next Earnings (Estimated): 11/05/2026
• Dividend Payable: 11/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Real Estate
• Industry: Healthcare REITs
• Sub-Industry: Healthcare REITs
• Current Symbol: NYSE:NHI
• CIK: 877860
• Web: www.nhireit.com
• Phone: (615) 890-9100
• Fax: 615-225-3030
• Employees: 32
• Year Founded: 1991

Price Target and Rating

• Average Price Target for National Health Investors: $82.25
• High Price Target: $94.00
• Low Price Target: $78.00
• Potential Upside/Downside: +21.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.56
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $3.46
• Trailing P/E Ratio: 19.56
• Forward P/E Ratio: 14.22
• P/E Growth: 3.62
• Net Income: $142.18 million
• Net Margins: 38.56%
• Pretax Margin: 38.80%
• Return on Equity: 10.89%
• Return on Assets: 5.88%

Debt

• Debt-to-Equity Ratio: 0.81
• Current Ratio: 6.78
• Quick Ratio: 6.78

Sales & Book Value

• Annual Sales: $375.63 million
• Price / Sales: 8.85
• Cash Flow: $4.78 per share
• Price / Cash Flow: 14.15
• Book Value: $32.11 per share
• Price / Book: 2.11

Miscellaneous

• Outstanding Shares: 49,110,000
• Free Float: 47,784,000
• Market Cap: $3.32 billion
• Optionable: Optionable
• Beta: 0.52